COVID-19 is an emerging, rapidly evolving situation.
Get the latest information from CDC (Coronavirus.gov) | NIH Resources | NIDA Resources
Heroin + Opioids + Pain Medication + Prescription Drugs News Releases
-
Vaping of marijuana on the rise among teens (December 18, 2019)
NIH’s 2019 Monitoring the Future survey finds continuing declines in prescription opioid misuse, tobacco cigarettes, and alcohol. -
Marijuana use at historic highs among college-age adults (September 13, 2019)
New survey now online. -
-
NIH establishes network to improve opioid addiction treatment in criminal justice settings (July 24, 2019)
Ten clinical research centers will address gaps in accessing high-quality care. -
Project to deter opioid tampering wins 2019 NIDA Addiction Science Award (May 17, 2019)
NIDA announces awardees at the 2019 Intel International Science and Engineering Fair. -
National Institute on Drug Abuse Intramural Research Program Holds Opioid Symposium (May 15, 2019)
Media Advisory. -
-
-
Opioid Overdose Reversal News: FDA-approved naloxone devices produce substantially higher blood levels of naloxone than improvised nasal spray (March 15, 2019)
Science Spotlight. -
Monthly buprenorphine injections effective for opioid use disorders (February 19, 2019)
Study results on long-acting injection formulation now published. -
-
-
Study shows impact of social interactions on addictive behavior (October 15, 2018)
Science Spotlight. -
-
-
-
Training module now available for acute pain management in hospitalized adults (June 27, 2018)
New online course is 10th in a series developed by the NIH Pain Consortium. -
Analysis of insurance coverage for back pain shows missed opportunities to prescribe non-opioid medications (June 22, 2018)
Science Spotlight. -
Methadone and buprenorphine reduce risk of death after opioid overdose (June 19, 2018)
NIH research confirms effective treatments for opioid use disorder are underutilized. -
-
Study upends conventional view of opioid mechanism of action (May 10, 2018)
NIH-funded scientists find new molecular target for developing safer pain medications. -
-
Understanding the Neuroscience of Addiction: what it means for prevention and treatment (April 25, 2018)
Announcement. -
-
Medication in Prison Associated with Reductions in Fatal Opioid Overdoses After Release (February 14, 2018)
Science Spotlight. -
Kappa Opioid Receptor Structure Revealed, A Potential Milestone in Medication Development (January 04, 2018)
Science Spotlight. -
-
Separating side effects could hold key for safer opioids (November 16, 2017)
NIH-funded scientists may have revealed brain functions in pre-clinical research that widen the safety margin for opioid pain relief without overdose . -
Opioid treatment drugs have similar outcomes once patients initiate treatment (November 14, 2017)
NIDA study compares buprenorphine/naloxone combination to extended release naltrexone. -
Study identifies a brain pathway involved in drug relapse after cessation of contingency management (October 11, 2017)
Science Spotlight.
